Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 11, 2005. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting specific share transactions and does not contain financial performance data.
Material Changes
On May 10, 2005, the GlaxoSmithKline Employee Trust (GSK Trust) transferred 6,778 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. The company was advised of these transactions on May 11, 2005.
Outlook, Risks, and Management Commentary
The filing contains no guidance, outlook, management commentary, risks, contingencies, or unusual items. It strictly details the mechanics of the share transfer and the status of the GSK Trust as a discretionary trust for current and former employees.
Key Facts for Investor Verification
- Transaction Date: May 10, 2005.
- Shares Transferred: 6,778 Ordinary Shares.
- Beneficiaries: Participants in the SmithKline Beecham Employee Share Option Plan 1991.
- Directors' Interests: Directors Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop hold interests in the GSK Trust shares in the same capacity as other employees.
- Financial Data: No financial metrics are included in this specific filing.